SHELL ASSET MANAGEMENT CO - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$37,000
+23.3%
6,314
-11.4%
0.00%0.0%
Q2 2022$30,000
-54.5%
7,127
+2.2%
0.00%
-50.0%
Q1 2022$66,000
-56.6%
6,973
-12.8%
0.00%
-33.3%
Q4 2021$152,000
-41.5%
7,997
+2.5%
0.00%
-50.0%
Q3 2021$260,000
-17.7%
7,804
-4.1%
0.01%0.0%
Q2 2021$316,000
-54.3%
8,134
-43.3%
0.01%
-57.1%
Q1 2021$691,000
+38.2%
14,345
+49.3%
0.01%
+40.0%
Q4 2020$500,0009,6060.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders